Issue 57, 2017

DNA or protein? Capillary zone electrophoresis–mass spectrometry rapidly elucidates metallodrug binding selectivity

Abstract

A novel capillary zone electrophoresis–mass spectrometry (CZE–MS) approach allows the simultaneous characterization and quantification of the binding of metal-based anticancer agents to biomolecules. Moreover, for the first time, oligonucleotide metallation was resolved at single-nucleotide resolution by MS.

Graphical abstract: DNA or protein? Capillary zone electrophoresis–mass spectrometry rapidly elucidates metallodrug binding selectivity

Supplementary files

Article information

Article type
Communication
Submitted
13 Jun 2017
Accepted
25 Jun 2017
First published
27 Jun 2017

Chem. Commun., 2017,53, 8002-8005

DNA or protein? Capillary zone electrophoresis–mass spectrometry rapidly elucidates metallodrug binding selectivity

C. Artner, H. U. Holtkamp, W. Kandioller, C. G. Hartinger, S. M. Meier-Menches and B. K. Keppler, Chem. Commun., 2017, 53, 8002 DOI: 10.1039/C7CC04582D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements